Amedisys announced that its board of directors has authorized a stock repurchase program, under which the company may repurchase up to $100M of its outstanding common stock through December 31.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMED:
- Amedisys Board of Directors Authorizes $100 Million Stock Repurchase Program
- Amedisys Honors 39 Employees With Annual Spirit Of Excellence Award
- Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Dates
- Amedisys price target lowered to $120 from $135 at Benchmark
- Amedisys price target lowered to $115 from $140 at Credit Suisse
